all report title image

MACROLIDE ANTIBIOTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Macrolide Antibiotics Market, By Drug Type (Azithromycin, Clarithromycin, Erythromycin, Roxithromycin, Fidaxomicin, and Other Macrolides), By Indication (Respiratory Infections, Skin and Soft Tissue Infections, Gastrointestinal Infections, Sexually Transmitted Infections, Eye Infections, and Other Infections), By Age Group (Pediatric, Adult, and Geriatric), By Type (Branded Macrolides and Generic Macrolides), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Homecare Settings, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 17 Mar, 2026
  • Code: CMI8670
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Macrolide Antibiotics Market, By Drug Type
      • Global Macrolide Antibiotics Market, By Indication
      • Global Macrolide Antibiotics Market, By Age Group
      • Global Macrolide Antibiotics Market, By Type
      • Global Macrolide Antibiotics Market, By Route of Administration
      • Global Macrolide Antibiotics Market, By Distribution Channel
      • Global Macrolide Antibiotics Market, By End User
      • Global Macrolide Antibiotics Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Macrolide Antibiotics Market, By Drug Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Azithromycin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Clarithromycin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Erythromycin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Roxithromycin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Fidaxomicin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Other Macrolides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Macrolide Antibiotics Market, By Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Respiratory Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Skin and Soft Tissue Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Gastrointestinal Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Sexually Transmitted Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Eye Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Other Infections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Macrolide Antibiotics Market, By Age Group, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Macrolide Antibiotics Market, By Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Branded Macrolides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Generic Macrolides
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Macrolide Antibiotics Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Macrolide Antibiotics Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Macrolide Antibiotics Market, By End User, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022- 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ambulatory Surgical Centers (ASCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Homecare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  11. Global Macrolide Antibiotics Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  12. Competitive Landscape

    • Pfizer Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alkem Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Zydus Lifesciences Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Lupin Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  13. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  14. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Macrolide Antibiotics Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.